Cocaine effects on the developing brain: Current status

Neuroscience and Biobehavioral Reviews

Volumn 27, Issue 8, 2004, Pages 751-764

  Harvey, John A ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Attention; Dopamine; Eyeblink conditioning, rabbit, rodent, primate, human; Frontocingulate cortex; Learning; Neurogenesis; Prenatal cocaine

Indexed keywords

COCAINE; DOPAMINE 1 RECEPTOR;

ATTENTION; BRAIN CELL; BRAIN DEVELOPMENT; CELL DISRUPTION; CINGULATE GYRUS; COCAINE DEPENDENCE; COGNITIVE DEFECT; CONFERENCE PAPER; DRUG EFFECT; MOLECULAR MIMICRY; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYNAPTOGENESIS;

EID: 1042266420     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2003.11.006     Document Type: Conference Paper

References (141)

1. Kozell N.J., Adams E.H. Epidemiology of drug abuse: an overview. Science (Washington). 234:1986;970-974.
2. Ostrea E.M. Jr, Brady M., Gause S., Raymundo A.L., Stevens M. Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study. Pediatrics. 89:1992;107-113.
3. National Pregnancy and Health Survey; 1995.
4. Gingras J.L., Weese-Mayer D.E., Hume R.F. Jr, O'Donnell K.J. Cocaine and development: mechanisms of fetal toxicity and neonatal consequences of prenatal cocaine exposure. Early Human Dev. 31:1992;1-24.
5. Hutchings D.E. The puzzle of cocaine's effects following maternal use during pregnancy: are there reconcilable differences? Neurotoxicol Teratol. 15:1993;281-286.
6. Harvey J.A., Kosofsky B.E. Cocaine: effects on the developing brain. Ann NY Acad Sci. 846:1998.
7. Harvey J.A., Romano A.G., Gabriel M., Simansky K.J., Du W., Aloyo V.J., Friedman E. Effects of prenatal exposure to cocaine on the developing brain: anatomical, chemical, physiological and behavioral consequences. Neurotoxicol Res. 3:2000;117-143.
8. Denenberg V.H., Zeidner L.P., Thoman E.B., Kramer P., Rowe J.C., Philipps A.F., Raye J.R. Effects of theophylline on behavioral state development in newborn rabbit. J Pharmacol Exp Ther. 221:1982;604-608.
9. Kasirsky G., Tansy M.F. Teratogenic effects of methamphetamine in mice and rabbits. J Am Osteopath Assoc. 70:1971;1119-1120.
10. Hartman H.A. The fetus in experimental teratology. Flatt R.E., Kraus A.L. The biology of the laboratory rabbit. 1974;92-144 Academic Press, New York.
11. Hudson R., Distel H. The potential of the newborn rabbit for behavioral teratological research. Neurobehav Toxicol Teratol. 8:1986;209-212.
12. Harel S., Watanabe K., Linke I., Schain R.J. Growth and development of the rabbit brain. Biol Neonate. 21:1972;381-399.
13. Reader T.A., Dewar K.M. Endogenous homovanillic acid levels differ between rat and rabbit caudate, hippocampus, and cortical regions. Neurochem Res. 14:1989;1137-1141.
14. Jones R.T. The pharmacology of cocaine smoking in humans. Chiang C.N., Hawks R.L. Research findings in smoking of abused substances. National Institute on Drug Abuse Research Monograph 99. 1990;US Government Printing Office.
15. Harvey J.A. Effect of drugs on associative learning. Meltzer H. Psychopharmacology, the third generation of progress. 1987;1485-1491 Raven Press, New York.
16. Schindler C.W., Harvey J.A. The use of classical conditioning procedures in behavioral pharmacology. Dworkin S.I., Higgins S.T., Bickel W.K. Contemporary research in behavioral pharmacology. Drug Development Research. vol. 20:1990;169-187.
17. Romano A.G., Harvey J.A. Drug effects on sensorimotor integration in a model system. Watson R.R. Drugs of abuse and neurobiology. 1992;23-37 CRC Press, Boca Raton, FL.
18. Gabriel M. Functions of anterior and posterior cingulate cortex during avoidance learning in rabbits. In Progress in Brain Research. vol. 85:1990;Elsevier, New York. p. 467-83.
19. Murphy E.H., Hammer J.G., Schumann M.D., Groce M.Y., Wang X.-H., Jones L., Romano A.G., Harvey J.A. The rabbit as a model for studies of cocaine exposure in utero. Lab Animal Sci. 45:1995;94-101.
20. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J. Cocaine receptors on dopamine transporter are related to self administration of cocaine. Science. 237:1987;1219-1223.
21. Ritz M.C., Cone E.J., Kuhar M.J. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci. 46:1990;635-645.
22. Meyer J., Shearman L.P., Collins M., Maguire R.L. Cocaine binding sites in fetal rat brain: implications for prenatal cocaine action. Psychopharmacology. 112:1993;445-451.
23. Kebabian J.W., Petzold G.L., Greengard P. Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the 'dopamine receptor'. Proc Natl Acad Sci USA. 69:1972;2145-2149.
24. 1 dopamine receptor linked to adenylyl cyclase activation. Proc Natl Acad Sci USA. 87:1990;6723-6727.
25. Senogles S.E., Spiegel A.M., Padrell E., Iyengar R., Caron M.G. Specificity of receptor-G protein interactions: discrimination of Gi subtypes by the D2 dopamine receptor in a reconstituted system. J Biol Chem. 265:1990;4507-4514.
26. 1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphates formation. Mol Pharmacol. 48:1995;988-994.
27. 1A knockout mice. Mol Pharmacol. 51:1997;6-11.
28. Olson L., Seiger A. Early prenatal ontogeny of central monoamine neurons in the rat: fluorescent histochemical observations. Anat Ent-Gesh. 137:1972;301-316.
29. Olson L., Blreus L.O., Seiger A. Histochemical demonstration and mapping of 5-hydroxytryptamine and catecholamine containing neuron systems in the human fetal brain. Anat Ent-Gesh. 139:1973;259-282.
30. 3H-dopamine uptake. Brain Res. 46:1972;251-285.
31. Tennyson V.M., Mytilineou C., Barrett R.E. Fluorescence and electron microscopic studies of the early development of the substantia nigra and area ventralis tegmenti in the fetal rabbit. J Comp Neurol. 149:1973;233-257.
32. 1 dopamine receptor-mediated activation of striatal Gs proteins. J Pharmacol Exp Ther. 273:1995;492-498.
33. Friedman E., Yadin E., Wang H.-Y. Effect of prenatal cocaine on dopamine receptor-G protein coupling in mesocortical regions of the rabbit brain. Neuroscience. 70:1996;739-747.
34. 2 dopamine binding associated with an increase in ligand affinity. Pharmacol Biochem Behav. 37:1990;371-373.
35. Henderson M.G., McConnaughey M.M., McMillen B.A. Long-term consequences of prenatal exposure to cocaine or related drugs: effects on rat brain monoaminergic receptors. Brain Res Bull. 26:1991;941-945.
36. 1 dopamine receptor function in rat nucleus accumbens and striatum. Brain Res. 573:1992;331-335.
37. Leslie C.A., Robertson M.W., Jung A.B., Liebermann J., Bennett J.P. Jr. Effects of prenatal cocaine exposure upon postnatal development of neostriatal dopaminergic function. Synapse. 17:1994;210-215.
38. Choi S.J., Mazzio E., Soliman K.F. The effects of gestational cocaine exposure on pregnancy outcome, postnatal development, cognition and locomotion in rats. Ann NY Acad Sci. 844:1998;324-335.
39. Ronnekleiv O.K., Fang Y., Choi W.S., Chai L. Changes in the midbrain-rostral forebrain dopamine circuitry in the cocaine-exposed primate fetal brain. Harvey J.A., Kosofsky B.E. Cocaine: effects on the developing brain. Annales of the New York Academy of Sciences. vol. 846:1998;165-181.
40. Lidow M.S., Trakht T., Howard R.L. Cocaine-induced alterations in the density of monoaminergic receptors in the embryonic guinea pig cerebral wall. Synapse. 32:1999;225-237.
41. Friedman E., Wang H.Y. Prenatal cocaine exposure alters signal transduction in the brain D1 dopamine receptor system. Harvey J.A., Kosofsky B.E. Cocaine: effects on the developing brain. Annales of the New York Academy of Sciences. vol. 846:1998;238-247.
42. Tilakaratne N., Cai G.P., Friedman E. Cocaine-induced activation of c-fos gene expression is attenuated in prenatal cocaine-exposed rabbits. Harvey J.A., Kosofsky B.E. Cocaine: effects on the developing brain. Annales of the New York Academy of Sciences. vol. 846:1998;368-370.
43. Tilakaratne N., Cai G.P., Friedman E. Attenuation of cocaine-induced genomic and functional responses in prenatal cocaine-exposed rabbits. Pharmacol Biochem Behav. 69:2001;225-232.
44. 2 dopamine receptors in amphetamine-induced changes in striatal unit activity in behaving rats. Brain Res. 619:1993;347-351.
45. Simansky K.J., Kachelries W.J. Prenatal exposure to cocaine selectively disrupts motor responding to D-amphetamine in young and mature rabbits. Neuropharmacology. 35:1996;71-78.
46. Lidow M.S. Nonhuman primate model of the effect of prenatal cocaine exposure on cerebral cortical development. Harvey J.A., Kosofsky B.E. Cocaine: effects on the developing brain. Annales of the New York Academy of Sciences. vol. 846:1998;182-193.
47. Greengard P., Allen P.B., Nairn A.C. Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron. 23:1999;435-447.
48. Zhen X., Torres C., Wang H.Y., Friedman E. Prenatal exposure to cocaine disrupts D1A dopamine receptor function via selective inhibition of protein phosphatase 1 pathway in rabbit frontal cortex. J Neurosci. 21:2001;9160-9167.
49. Svenningsson P., Lindskog M., Ledent C., Parmentier M., Greengard P., Fredholm B.B., Fiscone G. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc Natl Acad Sci USA. 97:2000;1856-1860.
50. Jones L.B., Fischer I., Levitt P. Nonuniform alteration of dendritic development in the cerebral cortex following prenatal cocaine exposure. Cereb Cortex. 6:1996;431-445.
51. Levitt P., Harvey J.A., Friedman E., Simansky K., Murphy E.H. New evidence for neurotransmitter influences on brain development. Trends Neurosci. 20:1997;269-274.
52. Jones L.B., Stanwood G.D., Reinoso B.S., Washington R.A., Wang H.Y., Friedman E., Levitt P. In utero cocaine-induced dysfunction of dopamine D1 recepor signaling and abnormal differentiation of cerebral cortical neurons. J Neurosci. 20:2000;4606-4614.
53. Stanwood G.D., Washington R.A., Shumsky J.S., Levitt P. Prenatal cocaine exposure produces consistent developmental alterations in dopamine-rich regions of the cerebral cortex. Neuroscience. 106:2001;5-14.
54. Stanwood G.D., Washington R.A., Levitt P. Identification of a sensitive period of prenatal cocaine exposure that alters the development of the anterior cingulate cortex. Cereb Cortex. 11:2001;430-440.
55. Reinoso B.S., Undie A.S., Levitt P. Dopamine receptors mediated differential morphological effects on cerebral cortical neurons in vitro. J Neurosci Res. 43:1996;439-453.
56. Dos Santos Rodrigues P., Dowling J.E. Dopamine induces neurite retraction in retinal horizontal cells via diacylglycerol and protein kinase C. Proc Natl Acad Sci. 87:1990;9693-9697.
57. Zachor D.A., Moore J.F., Jin J., Theibert A.B., Percy A.K. C-fos mediates cocaine inhibition of NGF-induced PC12 cell differentiation. Mol Genet Metab. 64:1998;62-69.
58. Zachor D.A., Moore J.F., Brezausek C., Theibert A., Percy A.K. Cocaine inhibits NGF-induced PC12 cells differentiation through D(1)-type dopamine receptors. Brain Res. 869:2000;85-97.
59. Zachor D.A., Moore J.F., Brezausek C.M., Theibert A.B., Percy A.K. Cocaine inhibition of neuronal differentiation in NGF-induced PC12 cells is independent of ras signaling. Int J Dev Neurosci. 18:2000;765-772.
60. Snow D.M., Smith J.D., Booze R.M., Welch M.A., Mactutus C.F. Cocaine decreases cell survival and inhibits neurite extension of rat locus coeruleus neurons. Neurotoxicol Teratol. 23:2001;225-234.
61. Kosofsky B.E., Wilkins A.S., Gressens P., Evrard P. Transplacental cocaine exposure - a mouse model demonstrating neuroanatomic and behavioral abnormalities. J Child Neurol. 9:1994;234-241.
62. Nassogne M.C., Gressens P., Evrard P., Courtoy P.J. In contrast to cocaine, prenatal exposure to methadone does not produce detectable alterations in the developing mouse brain. Brain Res Dev Brain Res. 110:1998;61-67.
63. Baraban S.C., Wenzel H.J., Castro P.A., Schwartzkroin P.A. Hippocampal dysplasia in rats exposed to cocaine in utero. Brain Res Dev Brain Res. 117:1999;213-217.
64. Lidow M.S., Song Z.M. Primates exposed to cocaine in utero display reduced density and number of cerebral cortical neurons. J Comp Neurol. 435:2001;263-275.
65. Lidow M.S., Bozian D., Song Z.-M. Cocaine affects cerebral neocortical cytoarchitecture in primates only if administered during neocortical neurogenesis. Dev Brain Res. 128:2001;45-52.
66. Williams G.W., Goldman-Rakic P.S. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature. 376:1995;572-575.
67. Granon S., Passetti F., Thomas K.L., Dalley J.W., Barry J., Everitt B.J., Robbins T.W. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci. 20:2000;1208-1215.
68. Harvey J.A., Gormezano I. Effect of haloperidol and pimozide on classical conditioning of the rabbit nictitating membrane response. J Pharmacol Exp Ther. 218:1981;712-719.
69. Kao K.T., Powell D.A. Lesions of the substantia nigra retard Pavlovian eye-blink but not heart rate conditioning in the rabbit. Behav Neurosci. 102:1988;515-525.
70. Winsky L., Harvey J.A. 6-Hydroxydopamine induced impairments of Pavlovian conditioning in the rabbit. Neurochem Res. 17:1992;415-422.
71. 1-mediated motor function but spares the enhancement of learning by amphetamine in rabbits. Harvey J.A., Kosofsky B.E. Cocaine: effects on the developing brain. Annales of the New York Academy of Sciences. vol. 846:1998;375-378.
72. Kronforst-Collins M.A., Disterhoft J.F. Lesions of the caudal area of rabbit medial prefrontal cortex impair trace eyeblink conditioning. Neurobiol Learn Mem. 69:1998;147-162.
73. Gibbs C.M., Powell D.A. Single-unit activity in the dorsomedial prefrontal cortex during the expression of discriminative bradycardia in rabbits. Behav Brain Res. 43:1991;79-92.
74. Pardo J.V., Pardo P.J., Janer K.W., Raichle M.E. The anterior cingulate cortex mediates processing selection in the Stroop attentional conflict paradigm. Proc Natl Acad Sci USA. 87:1990;256-259.
75. Petersen S.E., Fox P.E., Posner M.I., Mintum M., Raichle M.E. Positron emission tomographic studies of the cortical anatomy of single-word processing. Nature. 331:1988;585-589.
76. Corbetta M., Miezin F.M., Dobmeyer S., Shulman G.L., Petersen S.E. Selective and divided attention during visual discriminations of shape, color, and speed: functional anatomy by positron emission tomography. J Neurosci. 11:1991;2383-2402.
77. Romano A.G., Kachelries W.J., Simansky K.J., Harvey J.A. Intrauterine exposure to cocaine produces a modality specific acceleration of classical conditioning in adult rabbits. Pharmacol Biochem Behav. 52:1995;415-420.
78. Mackintosh N.J. A theory of attention: variations in the associability of stimuli with reinforcement. Psychol Rev. 82:1975;276-298.
79. Romano A.G., Harvey J.A. Prenatal exposure to cocaine disrupts discrimination learning in adult rabbits. Pharmacol Biochem Behav. 53:1996;617-621.
80. Wilkins A.S., Kosofsky B.E., Romano A.G., Harvey J.A. Transplacental cocaine exposure: behavioral consequences. Konkol R.J., Olsen G. Prenatal cocaine exposure. 1996;149-165 CRC Press, Boca Raton, Fl.
81. Gabriel M. Discriminative avoidance learning: a model system. Vogt B., Gabriel M. Neurobiology of cingulate cortex and limbic thalamus: a comprehensive handbook. 1993;478-523 Birkhäuser, Boston, MA.
82. Taylor C., Freeman J.H. Jr, Holt W., Gabriel M. Impairment of Cingulothalamic learning-related neuronal coding in rabbits exposed to cocaine in utero: general and sex-specific effects. Behav Neurosci. 113:1999;62-77.
83. Gabriel M., Taylor C. Prenatal exposure to cocaine impairs neuronal coding of attention and discriminative learning. Harvey J.A., Kosofsky B.E. Cocaine: effects on the developing brain. Annales of the New York Academy of Sciences. vol. 846:1998;194-212.
84. Mactutus C.F. Prenatal intravenous cocaine adversely affects attentional processing in preweanling rats. Neurotoxicol Teratol. 21:1999;539-550.
85. Garavan H., Morgan R.E., Mactutus C.F., Levitsky D.A., Booze R.M., Strupp B.J. Prenatal cocaine exposure impairs selective attention: evidence from serial reversal and extradimensional shift tasks. Behav Neurosci. 114:2000;725-738.
86. Bayer L.E., Brown A., Mactutus C.F., Booze R.M., Strupp B.J. Prenatal cocaine exposure increases sensitivity to the attentional effects of the dopamine D1 agonist SKF81297. J Neurosci. 20:2000;8902-8908.
87. Morgan R.E., Garavan H.P., Mactutus C.F., Levitsky D.A., Booze R.M., Strupp B.J. Enduring effects of prenatal cocaine exposure on attention and reaction to errors. Behav Neurosci. 116:2002;624-633.
88. Bayer L.E., Kakumanu S., Mactutus C.F., Booze R.M., Strupp B.J. Prenatal cocaine exposure alters sensitivity to the effects of idazoxan in a distraction task. Behav Brain Res. 133:2002;185-196.
89. Heyser C.J., Chen W.-J., Miller J., Spear N.E., Spear L.P. Prenatal cocaine exposure induces deficits in Pavlovian conditioning and sensory preconditioning among infant rat pups. Behav Neurosci. 104:1990;955-963.
90. Heyser C.J., Spear N.E., Spear L.P. Effects of prenatal exposure to cocaine on conditional discrimination learning in adult rats. Behav Neurosci. 106:1992;837-845.
91. Brunzell D.H., Ayres J.J., Meyer J.S. Effects of prenatal cocaine exposure on latent inhibition in 1-year-old female rats. Pharmacol Biochem Behav. 72:2002;795-802.
92. Kosofsky B.E., Wilkins A.S. A mouse model of transplacental cocaine exposure. Clinical implications for exposed infants and children. Harvey J.A., Kosofsky B.E. Cocaine: effects on the developing brain. Annales of the New York Academy of Sciences. vol. 846:1998;248-261.
93. Wilkins A.S., Genova L.M., Posten W., Kosofsky B.E. Transplacental cocaine exposure 1: a rodent model. Neurotoxicol Teratol. 20:1998;1-11.
94. Johns J.M., Means M.J., Anderson D.R., Means L.W., McMillen B.A. Prenatal exposure to cocaine. II. Effects on open-field activity and cognitive behavior in Sprague-Dawley rats. Neurotoxicol Teratol. 14:1992;343-349.
95. Cutler A.R., Wilkerson A.E., Gingras J.L., Levin E.D. Prenatal cocaine and/or nicotine exposure in rats: preliminary findings on long-term cognitive outcome and genital development at birth. Neurotoxicol Teratol. 18:1996;635-643.
96. Heyser C.J., Spear N.E., Spear L.P. Effects of prenatal exposure to cocaine on Morris water maze performance in adult rats. Behav Neurosci. 109:1995;734-743.
97. Voorhees C.V., Reed T.M., Acuff-Smith K.D., Schilling M.A., Cappon G.D., Fisher J.E., Cunfeng P. Long-term learning deficits and changes in unlearned behaviors following in utero exposure to multiple daily doses of cocaine during different exposure periods and maternal plasma cocaine concentrations. Neurotoxicol Teratol. 17:1995;253-264.
98. Choi S.J., Mazzio E., Kolta M.G., Soliman K.F. Prenatal cocaine exposure affects postnatal dopaminergic systems in various regions of the rat brain. Ann NY Acad Sci. 844:1998;293-302.
99. Levin E.D., Seidler F.J. Sex-related spatial learning differences after prenatal cocaine exposure in the young adult rat. Neurotoxicol Teratol. 14:1993;23-28.
100. Morrow B.A., Elsworth J.D., Roth R.H. Prenatal cocaine exposure disrupts non-spatial, short-term memory in adolescent and adult male rats. Behav Brain Res. 129:2002;217-223.
101. Paule M.G., Gillam M.P., Allen R.R., Chelonis J.J. Effects of chronic in utero exposure to cocaine on behavioral adaptability in rhesus monkey offspring when examined in adulthood. Ann NY Acad Sci. 914:2000;412-417.
102. Choi S.J., Mazzio E.A., Reams R.R., Soliman K.F. Gestational cocaine exposure alters postnatal pituitary-adrenal axis activity and stress endurance in rats. Ann NY Acad Sci. 844:1998;336-345.
103. Willford J.A., Segar T.M., Barron S. The behavioral response to novelty is altered in rats neonatally exposed to cocaine. Dev Psychobiol. 35:1999;343-351.
104. Hahn M.E., Benno R.H., Schanz N., Phadia E. The effects of prenatal cocaine exposure and genotype on the ultrasonic calls of infant mice. Pharmacol Biochem Behav. 67:2000;729-738.
105. Huber J., Darling S., Park K., Soliman K.F. Altered responsiveness to stress and NMDA following prenatal exposure to cocaine. Physiol Behav. 72:2001;181-188.
106. Sobrian S.K., Marr L., Ressman K. Prenatal cocaine and/or nicotine exposure produces depression and anxiety in aging rats. Prog Neuropsychopharmacol Biol Psychiatry. 27:2003;501-518.
107. Elsworth J.D., Morrow B.A., Roth R.H. Prenatal cocaine exposure increases mesoprefrontal dopamine neuron responsivity to mild stress. Synapse. 42:2001;80-83.
108. Morrow B.A., Elsworth J.D., Roth R.H. Prenatal exposure to cocaine reduces the number and enhances reactivity of A10 dopaminergic neurons to environmental stress. Synapse. 41:2001;337-344.
109. Morrow B.A., Elsworth J.D., Roth R.H. Male rats exposed to cocaine in utero demonstrate elevated expression of Fos in the prefrontal cortex in response to environment. Neuropsychopharmacology. 26:2002;275-285.
110. Rocha B.A., Mead A.N., Kosofsky B.E. Increased vulnerability to self-administer cocaine in mice prenatally exposed to cocaine. Psychopharmacology. 163:2002;221-229.
111. Mitra S.C., Seshan S.V., Salcedo J.R., Gil J. Maternal cocaine abuse and fetal renal arteries: a morphometric study. Pediatr Nephrol. 14:2000;315-318.
112. Frank D.A., McCarten K.M., Robson C.D., Mirochnick M., Cabral H., Park H., Zuckerman B. Level of in utero cocaine exposure and neonatal ultrasound findings. Pediatrics. 104:1999;1101-1105.
113. Regalado M.G., Schechtman V.L., Khoo M.C., Bean X.D. Spectral analysis of heart rate variability and respiration during sleep in cocaine-exposed neonates. Clin Physiol. 21:2001;428-436.
114. Mehta S.K., Super D.M., Salvator A., Singer L., Connuck D., Fradley L.G., Harcar-Seveik R.A., Kaufman E.S. Heart rate variability in cocaine-exposed newborn infants. Am Heart J. 142:2001;828-832.
115. Mehta S.K., Super D.M., Salvator A., Singer L., Connuck D., Fradley L.G., Harcar-Seveik R.A., Thomas J.D., Sun J.P. Diastolic filling abnormalities by color kinesis in newborns exposed to intrauterine cocaine. J Am Soc Echocardiogr. 15:2002;447-453.
116. Mehta S.K., Super D.M., Connuck D., Kirchner H.L., Salvator A., Singer L., Fradley L.G., Kaufman E.S. Autonomic alterations in cocaine-exposed infants. Am Heart J. 144:2002;1109-1115.
117. Bada H.S., Bauer C.R., Shankaran S., Lester B., Wright L.L., Das A., Poole K., Smeriglio V.L., Finnegan L.P., Maza P.L. Central and autonomic system signs with in utero drug exposure. Arch Dis Child Fetal Neonatal Ed. 87:2002;F106-F112.
118. Bateman D.A., Chiriboga C.A. Dose-response effect of cocaine on newborn head circumference. Pediatrics. 106:2000;E33.
119. Smith L.M., Chang L., Yonekura M.L., Gilbride K., Kuo J., Poland R.E., Walot I., Ernst T. Brain proton magnetic resonance spectroscopy and imaging in children exposed to cocaine in utero. Pediatrics. 107:2001;227-231.
120. Schneider J.W., Chasnoff I.J. Motor assessment of cocaine/polydrug exposed infants at age 4 months. Neurotoxicol Teratol. 14:1992;97-101.
121. Chiriboga C.A., Bateman D.A., Brust J.C.M., Hauser W.A. Neurologic findings in cocaine-exposed infants. Pediatr Neurol. 9:1993;115-119.
122. Arendt R., Angelopoulos J., Salvator A., Singer L. Motor development of cocaine-exposed children at age two years. Pediatrics. 103:1999;86-92.
123. Salamy A., Eldredge L., Anderson J., Bull D. Brain-stem transmission time in infants exposed to cocaine in utero. J Pediatr. 117:1990;627-629.
124. Lester B.M., Lagasse L., Seifer R., Tronick E.Z., Bauer C.R., Shankaran S., Bada H.S., Wright L.L., Smeriglio V.L., Liu J., Finnegan L.P., Maza P.L. The maternal lifestyle study (MLS): effects of prenatal cocaine and/or opiate exposure on auditory brain response at one month. J Pediatr. 142:2003;279-285.
125. Betancourt L., Fischer R., Giannetta J., Malmud E., Brodsky N.L., Hurt H. Problem-solving ability of inner-city children with and without in utero cocaine exposure. J Dev Behav Pediatr. 20:1999;418-424.
126. Dempsey D.A., Hajnal B., Partridge J.C., Jacobson S.N., Good W., Jones R.T., Ferriero D.M. Tone abnormalities are associated with maternal cigarette smoking during pregnancy an in utero cocaine-exposed infants. Pediatrics. 106:2000;P79-P85.
127. Hurt H., Malmud E., Betancourt L.M., Brodsky N.L., Giannetta J.M. A prospective comparison of developmental outcome of children with in utero cocaine exposure and controls using the Battelle Developmental Inventory. J Dev Behav Pediatr. 22:2001;27-34.
128. Addis A., Moretti M.E., Ahmed Syted F., Einarson T.R., Koren G. Fetal effects of cocaine: an updated meta-analysis. Reprod Toxicol. 15:2001;341-369.
129. Frank D.A., Augustyn M., Knight W.G., Pell T., Zuckerman B. Growth, developmental, and behavior in early childhood following prenatal cocaine exposure: a systematic review. J Am Med Assoc. 28:2001;1613-1625.
130. Mayes L.C., Granger R.H., Frank M.A., Schottenfeld R., Bornstein M.H. Neurobehavioral profiles of neonates exposed to cocaine prenatally. Pediatrics. 91:1993;778-783.
131. Mayes L.C., Bornstein M.H., Chawarska K., Granger R.H. Information processing and developmental assessments in 3-month-old infants exposed prenatally to cocaine. Pediatrics. 95:1995;539-545.
132. Richardson G.A., Conroy M.L., Day N.L. Prenatal cocaine exposure: Effects on the development of school-age children. Neurotoxicol Teratol. 18:1996;627-634.
133. Tronick E.Z., Frank D.A., Cabral H., Mirochnick M., Zuckerman B. Late dose-response effects of prenatal cocaine exposure on newborn neurobehavioral performance. Pediatrics. 98:1996;76-83.
134. Azuma S.D., Chasnoff I.J. Outcome of children prenatally exposed to cocaine and other drugs: a path analysis of three-year data. Pediatrics. 92:1993;396-402.
135. Koren G., Nulman I., Rovet J., Greenbaum R., Loebstein M., Einarson T. Long-term neurodevelopmental risks in children exposed in utero to cocaine. The Toronto adoption study. Harvey J.A., Kosofsky B.E. Cocaine: effects on the developing brain. Annales of the New York Academy of Sciences. vol. 846:1998;306-313.
136. Nulman I., Rovet J., Greenbaum R., Loebstein M., Wolpin J., Pace-Asciak P., Koren G. Neurodevelopment of adopted children exposed in utero to cocaine: the Toronto adoption study. Clin Invest Med. 24:2001;129-137.
137. Bandstra E.S., Morrow C.E., Vogel A.L., Fifer R.C., Ofir A.Y., Dausa A.T., Xue L., Anthony J.C. Longitudinal influence of prenatal cocaine exposure on child language functioning. Neurotoxicol Teratol. 24:2002;297-308.
138. Leech S.L., Richardson G.A., Goldschmidt L., Day N.L. Prenatal substance exposure: effects on attention and impulsivity of 6-year-olds. Neurotoxicol Teratol. 21:1999;109-118.
139. Potter S.M., Zelazo P.R., Stack D.M., Papageorgiou A.N. Adverse effects of fetal cocaine exposure on neonatal auditory information processing. Pediatrics. 105:2000;E40.
140. LaGasse L.L., Van Vorst R.F., Brunner S.M., Lester B.M. Effects of in utero exposure to cocaine and/or opiates on infants' reaching behavior. Harvey J.A., Kosofsky B.E. Cocaine: effects on the developing brain. Annales of the New York Academy of Sciences. vol. 846:1998;405-407.
141. Thyssen Van Beveren T., Little B.B., Spence M.J. Effects of prenatal cocaine exposure and postnatal environment on child development. Am J Human Biol. 12:2000;417-428.